IYH — iShares U.S. Healthcare ETF
Healthcare Ranked #198 of 458 tracked ETFs · Issued by iShares
IYH Price Performance — Growth of $10,000
Value of a $10,000 investment in IYH over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.
IYH Drawdown
The "underwater" chart: IYH's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.
What If You'd Invested in IYH?
See what a lump sum in IYH would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.
Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.
Overview
The iShares U.S. Healthcare ETF (IYH) is a healthcare sector fund issued by iShares that tracks a universe of 11 ETFs within its specific category. With $3.16 billion in assets under management and a share price of $68.41, the fund demonstrates significant investor adoption relative to its peers. It holds an overall rank of #198 out of 458 tracked ETFs across all categories, earning an ETFValuer grade of C with a score of 62.9 out of 100. The fund carries an expense ratio of 0.38% while offering a dividend yield of 4.28%, providing income alongside its growth potential. These metrics position IYH as a mid-tier option in terms of cost efficiency and yield generation within the broader ETF landscape. The substantial asset base suggests established liquidity and market presence for investors seeking exposure to the healthcare sector.
Over the last day, the fund posted a return of +0.63%, which accelerated to +0.90% over the one-week period. Monthly performance showed further strength with a +5.83% gain, leading into a three-month return of +11.63%. Despite this recent momentum, the six-month return moderated to +3.31%, while year-to-date gains stood at +5.26%. The one-year return reached +21.01%, indicating a strong annual performance trajectory. Extending the view to three years, the fund has accumulated a total return of +25.82%. This pattern reveals a period of significant acceleration in the short to medium term, contrasting with a more moderate six-month figure before the recent surge.
IYH carries a moderate volatility label and a beta of 0.52, suggesting the fund moves less than the broader market in either direction. A Sharpe ratio of 1.02 indicates that the fund has generated a favorable amount of excess return per unit of risk taken over the measured period. The maximum drawdown of -17.91% represents the largest peak-to-trough decline experienced by the fund during the analysis window. This combination of a low beta and moderate volatility implies the fund may offer some downside protection during market declines while still participating in upside moves. The Sharpe ratio further supports the view that the returns generated have been efficient relative to the volatility encountered. Investors should note that the maximum drawdown figure reflects the worst-case scenario loss observed in the historical data provided.
AI-generated summary based on the data on this page.
IYH Top Holdings
| # | Holding | % of Net Assets | Value |
|---|---|---|---|
| 1 | ELI LILLY AND COMPANY | 13.72% | $385M |
| 2 | JOHNSON & JOHNSON | 10.14% | $284M |
| 3 | ABBVIE INC. | 6.86% | $192M |
| 4 | UNITEDHEALTH GROUP INCORPORATED | 6.18% | $173M |
| 5 | MERCK & CO., INC. | 4.97% | $139M |
| 6 | AMGEN INC. | 3.41% | $96M |
| 7 | THERMO FISHER SCIENTIFIC INCORPORATED | 3.32% | $93M |
| 8 | GILEAD SCIENCES, INC. | 2.99% | $84M |
| 9 | INTUITIVE SURGICAL, INC. | 2.96% | $83M |
| 10 | ABBOTT LABORATORIES | 2.88% | $81M |
Holdings as of 2026-04-30 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 57.4% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how IYH's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.
Which Funds Overlap With IYH
Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with IYH's top 10 — VHT overlaps most, holding 9 of the same companies as IYH's top 10 (43.7% of IYH's assets).
| ETF | Name | Shared Companies | IYH Weight | Examples |
|---|---|---|---|---|
| VHT | Vanguard Health Care Index Fund ETF Shares | 9 | 43.7% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| XLV | State Street Health Care Select Sector SPDR ETF | 9 | 43.7% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| FHLC | Fidelity MSCI Health Care Index ETF | 9 | 43.7% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| DGRO | iShares Core Dividend Growth ETF | 3 | 23.2% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED |
| HDV | iShares Core High Dividend ETF | 3 | 22.0% | JOHNSON & JOHNSON, ABBVIE INC., MERCK & CO., INC. |
Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.
Market Backdrop
10-Year Treasury Yield: 4.71% (as of 2026-07-23) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.
CBOE Volatility Index (VIX): 18.70 (as of 2026-07-23) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.
Federal Funds Rate: 3.63% (as of 2026-06-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.
What IYH's Fees Cost You
IYH charges an expense ratio of 0.38% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.
Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.
IYH Dividend Income Estimator
IYH currently yields 4.28%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.
Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.
IYH Liquidity, Domicile & Tax Treatment
Liquidity: Quoted bid/ask spread is 1.49% and average daily volume is 774K/day. Tighter spreads and higher volume mean lower round-trip trading costs; this is a live-market snapshot and can widen during volatile sessions. AUM of $3.16B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.
Domicile & tax treatment: IYH is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.
IYH Performance History
| Period | Return |
|---|---|
| 1-Day | +0.63% |
| 1-Week | +0.90% |
| 1-Month | +5.83% |
| 3-Month | +11.63% |
| 6-Month | +3.31% |
| YTD | +5.26% |
| 1-Year | +21.01% |
| 3-Year | +25.82% |
How IYH Compares to Other Healthcare ETFs
| Rank | Grade | Ticker | Name | 1-Year | Exp. Ratio | AUM |
|---|---|---|---|---|---|---|
| #66 | B |
XBI | State Street SPDR S&P Biotech ETF | +71.35% | 0.35% | $10.7B |
| #69 | B |
VHT | Vanguard Health Care Index Fund ETF Shares | +23.45% | 0.09% | $20.4B |
| #92 | B |
XLV | State Street Health Care Select Sector SPDR ETF | +21.38% | 0.08% | $40.6B |
| #110 | B |
FHLC | Fidelity MSCI Health Care Index ETF | +23.55% | 0.084% | $3.22B |
| #122 | B |
XPH | State Street SPDR S&P Pharmaceuticals ETF | +57.67% | 0.35% | $428M |
| #125 | B |
IBB | iShares Biotechnology ETF | +39.29% | 0.44% | $9.09B |
| #172 | B |
PPH | VanEck Pharmaceutical ETF | +26.45% | 0.36% | $879M |
| #198 | C |
IYH | iShares U.S. Healthcare ETF | +21.01% | 0.38% | $3.16B |
| #293 | C |
IHF | iShares U.S. Healthcare Providers ETF | +30.54% | 0.38% | $1.18B |
| #389 | D |
ARKG | ARK Genomic Revolution ETF | +42.41% | 0.75% | $1.73B |
| #443 | F |
IHI | iShares U.S. Medical Devices ETF | -17.48% | 0.38% | $3.02B |